4//SEC Filing
David Matthew T 4
Accession 0001213900-20-025532
CIK 0001410098other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 8:38 AM ET
Size
7.8 KB
Accession
0001213900-20-025532
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
David Matthew T
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-09-03$4.07/sh+1,150$4,681→ 1,150 total
Holdings
- 125,000
Stock Option (Right to Buy Common Stock)
Exercise: $5.63Exp: 2030-05-11→ Common Stock (125,000 underlying) - 125,000
Stock Option (Right to Buy Common Stock)
Exercise: $4.08Exp: 2030-05-11→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date.
Documents
Issuer
CorMedix Inc.
CIK 0001410098
Entity typeother
Related Parties
1- filerCIK 0001811612
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 8:38 AM ET
- Size
- 7.8 KB